Victor Moyo
Chief Tech/Sci/R&D Officer at TRAWS PHARMA, INC.
Victor Moyo active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TRAWS PHARMA, INC. | Chief Tech/Sci/R&D Officer | 2023-10-23 | - |
OncoPep, Inc.
 OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Corporate Officer/Principal | 2022-04-30 | - |
Career history of Victor Moyo
Training of Victor Moyo
| University of Zimbabwe | Doctorate Degree |
Statistics
International
| United States | 3 |
| Zimbabwe | 2 |
Operational
| Corporate Officer/Principal | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoral
| Finance | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
OncoPep, Inc.
OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Finance |
- Stock Market
- Insiders
- Victor Moyo
- Experience